Best Fit Profiles
- insulin resistance and blood sugar management in metabolically impaired individuals
Insulin sensitivity and glucose metabolism
Chromium
Chromium picolinate is the best-studied form. Meta-analyses in type 2 diabetes show modest improvements in fasting glucose and HbA1c. Effects in non-diabetic populations are small and inconsistent.
Evidence Level B
Evidence and Risk Labels
Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.
See full scoring guideClinical Snapshot
- Effect Size
- Modest glucose-lowering in diabetic range; minimal effect in metabolically healthy adults
- Safety
- Low Risk
Hexavalent chromium (Cr VI) is toxic and carcinogenic — only trivalent forms (picolinate, chloride) are used in supplements; avoid in severe renal impairment.
Research Dosing
This reflects common ranges and protocols used in published studies, not personal medical advice.
- Typical Daily Dose
- 200-1000 mcg
- Timing
- With meals
- Protocol Duration in Studies
- 12-16 weeks minimum for metabolic endpoints
Picolinate form is most bioavailable and most studied.